XML 29 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
11. Segment Information
6 Months Ended
Jun. 30, 2017
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION

Information regarding industry segments for the three months ended June 30, 2017 and 2016 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2017
$
179.4

 
$
322.1

 
$
3.2

 
2016
$
180.0

 
$
333.7

 
$
3.1

 
 
 
 
 
 
 
Segment net (loss) profit
2017
$
(23.0
)
 
$
17.9

 
$
0.2

 
2016
$
(5.1
)
 
$
23.9

 
$
(0.3
)


Information regarding industry segments for the six months ended June 30, 2017 and 2016 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2017
$
353.6

 
$
644.4

 
$
6.7

 
2016
$
345.8

 
$
635.4

 
$
6.8

 
 
 
 
 
 
 
Segment net (loss) profit
2017
$
(41.8
)
 
$
58.9

 
$
0.4

 
2016
$
(8.4
)
 
$
48.6

 
$
0.1



Segment results are presented in the same manner as we present our operations internally to make operating decisions and assess performance.  Net corporate operating, interest and other expense for segment results consists of receipts and expenditures that are not the primary responsibility of segment operating management and therefore are not allocated to the segments for performance assessment by our chief operating decision maker.  Interest expense is charged to segments based on the carrying amount of inventory and receivables employed by that segment.  During the second quarter of 2017, our Clinical Diagnostics segment had an asset purchase for an early stage device for $7.5 million that was recorded in Research and development expense. See Note 13 for a discussion of restructuring costs. The following reconciles total segment profit to consolidated income before taxes (in millions):

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2017
 
2016
 
2017
 
2016
Total segment (loss) profit
$
(4.9
)
 
$
18.5

 
$
17.5

 
$
40.3

Foreign currency exchange losses, net
(2.5
)
 
(1.2
)
 
(4.3
)
 
(2.4
)
Net corporate operating, interest and other expense not allocated to segments
(3.3
)
 
(1.6
)
 
(5.1
)
 
(3.2
)
Other income (expense), net
11.8

 
11.2

 
13.2

 
12.4

Consolidated income before income taxes
$
1.1

 
$
26.9

 
$
21.3

 
$
47.1